CD4 and HIV infectious disease: The YWH participants were principally African American males, a population at heightened risk for HIV infection, who were treatment-naïve before enrollment, early in their disease course with CD4 T cell counts within the normal range and as a group have fewer comorbidities than adults [6,45].